{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T22:59:43Z","timestamp":1783033183692,"version":"3.54.6"},"reference-count":30,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.1016\/j.contraception.2010.02.009","type":"journal-article","created":{"date-parts":[[2010,5,24]],"date-time":"2010-05-24T04:29:03Z","timestamp":1274675343000},"page":"139-146","source":"Crossref","is-referenced-by-count":81,"title":["Effect of oral contraceptive containing ethinyl estradiol combined with drospirenone vs. desogestrel on clinical and biochemical parameters in patients with polycystic ovary syndrome"],"prefix":"10.1016","volume":"82","author":[{"given":"Alka","family":"Kriplani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anurekha Janaki","family":"Periyasamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nutan","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vidushi","family":"Kulshrestha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anand","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariachery Chinnama","family":"Ammini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.contraception.2010.02.009_bib1","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1210\/jc.2003-032046","article-title":"The prevalence and features of the polycystic ovary syndrome in an unselected population","volume":"89","author":"Azziz","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.contraception.2010.02.009_bib2","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1093\/humupd\/dmi005","article-title":"Combined oral contraceptives in the treatment of polycystic ovary syndrome","volume":"11","author":"Vrbikova","year":"2005","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.contraception.2010.02.009_bib3","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.ecl.2005.04.012","article-title":"Oral contraceptives and the management of hyperandrogenism-polycystic ovary syndrome in adolescents","volume":"34","author":"Hillard","year":"2005","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/j.contraception.2010.02.009_bib4","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.ecl.2005.04.005","article-title":"Polycystic ovary syndrome in adolescence","volume":"34","author":"Buggs","year":"2005","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/j.contraception.2010.02.009_bib5","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.bpobgyn.2004.05.007","article-title":"Hirsutism and acne in polycystic ovary syndrome","volume":"18","author":"Archer","year":"2004","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"10.1016\/j.contraception.2010.02.009_bib6","first-page":"19","article-title":"Antimineralocorticoid activity of a novel oral contraceptive containing drospirenone, a unique progestogen resembling natural progesterone","volume":"7","author":"Oelkers","year":"2002","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.contraception.2010.02.009_bib7","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1080\/713604397","article-title":"Effect of an oral contraceptive containing drospirenone and ethinylestradiol on general well-being and fluid-related symptoms","volume":"8","author":"Apter","year":"2003","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.contraception.2010.02.009_bib8","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome","volume":"81","year":"2004","journal-title":"Fertil Steril"},{"key":"10.1016\/j.contraception.2010.02.009_bib9","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1001\/archderm.113.1.31","article-title":"Effects of oral zinc and vitamin A in acne","volume":"113","author":"Michaelsson","year":"1977","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.contraception.2010.02.009_bib10","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1210\/jcem-21-11-1440","article-title":"Clinical assessment of body hair growth in women","volume":"21","author":"Ferriman","year":"1961","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.contraception.2010.02.009_bib11","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1530\/eje.0.1510241","article-title":"A mathematical comparison of techniques to predict biologically available testosterone in a cohort of 1072 men","volume":"151","author":"Morris","year":"2004","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.contraception.2010.02.009_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0010-7824(94)90106-6","article-title":"New progestogens in oral contraception","volume":"49","author":"Fotherby","year":"1994","journal-title":"Contraception"},{"issue":"suppl","key":"10.1016\/j.contraception.2010.02.009_bib13","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/S0002-9343(99)80067-9","article-title":"The androgenicity of progestins","volume":"98","author":"Darney","year":"1995","journal-title":"Am J Med"},{"key":"10.1016\/j.contraception.2010.02.009_bib14","first-page":"2073","article-title":"Update on oral contraceptive pills","volume":"60","author":"Cerel-Suhl","year":"1999","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.contraception.2010.02.009_bib15","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1210\/jc.80.6.1816","article-title":"Effects of new oral contraceptive containing an antimineralocorticoid progestogen drospirenone on the rennin-aldosterone system, body weight, blood pressure, glucose tolerance and lipid metabolism","volume":"80","author":"Oelkers","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.contraception.2010.02.009_bib16","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1783\/1471189041261636","article-title":"An observational study of Yasmin in the management of women with polycystic ovary syndrome","volume":"30","author":"Palep-Singh","year":"2004","journal-title":"J Fam Plann Reprod Health Care"},{"key":"10.1016\/j.contraception.2010.02.009_bib17","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1210\/jc.2003-031158","article-title":"Drospirenone for the treatment of hirsute women with polycystic ovary syndrome: a clinical, endocrinological, metabolic pilot study","volume":"89","author":"Guido","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"issue":"4 Suppl","key":"10.1016\/j.contraception.2010.02.009_bib18","first-page":"2","article-title":"The effect of 2 combined oral contraceptives containing either drospirenone or cyproterone acetate on acne and seborrhoea","volume":"69","author":"Van Vloten","year":"2002","journal-title":"Cutis"},{"key":"10.1016\/j.contraception.2010.02.009_bib19","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.fertnstert.2005.07.1311","article-title":"Efficacy of a new oral contraceptive containing drospirenone and ethinyl estradiol in the long term treatment of hirsutism","volume":"85","author":"Batukan","year":"2006","journal-title":"Fertil Steril"},{"issue":"3","key":"10.1016\/j.contraception.2010.02.009_bib20","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S1522-5720(02)00038-7","article-title":"Polycystic ovarian syndrome and insulin resistance","volume":"4","author":"McFarlane","year":"2002","journal-title":"Clin Fam Pract"},{"issue":"91","key":"10.1016\/j.contraception.2010.02.009_bib21","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.mcna.2007.06.010","article-title":"Obesity and the polycystic ovary syndrome","author":"Magnotti","year":"2007","journal-title":"Med Clin North Am"},{"key":"10.1016\/j.contraception.2010.02.009_bib22","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.maturitas.2008.03.009","article-title":"Clinical experiences with drospirenone: from reproductive to postmenopausal years","volume":"60","author":"Perez-Lopez","year":"2008","journal-title":"Maturitas"},{"key":"10.1016\/j.contraception.2010.02.009_bib23","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/S0015-0282(01)01834-9","article-title":"Effect of a combined oral contraceptive containing 3 mg of drospirenone and 30 microg of ethinyl estradiol on the human endometrium","volume":"76","author":"Ludicke","year":"2001","journal-title":"Fertil Steril"},{"key":"10.1016\/j.contraception.2010.02.009_bib24","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1093\/humrep\/16.7.1527","article-title":"Ovarian and endometrial function during hormonal contraception","volume":"16","year":"2001","journal-title":"Hum Reprod"},{"key":"10.1016\/j.contraception.2010.02.009_bib25","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0010-7824(00)00083-4","article-title":"An open-label, multicenter study to evaluate Yasmin, a low-dose combination oral contraceptive containing drospirenone, a new progestogen","volume":"61","author":"Parsey","year":"2000","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2010.02.009_bib26","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.contraception.2004.12.005","article-title":"Effects of two combined oral contraceptives containing ethinyl estradiol 20 microg combined with either drospirenone or desogestrel on lipids, hemostatic parameters and carbohydrate metabolism","volume":"71","author":"Klipping","year":"2005","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2010.02.009_bib27","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1210\/jc.2003-031281","article-title":"Ethinylestradiol-drospirenone, flutamide-metformin, or both for adolescents and women with hyperinsulinemic hyperandrogenism: opposite effects on adipocytokines and body adiposity","volume":"89","author":"Ibanez","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.contraception.2010.02.009_bib28","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0010-7824(02)00537-1","article-title":"A randomized study over 13 cycles to assess the influence of oral contraceptives containing ethinylestradiol combined with drospirenone or desogestrel on carbohydrate metabolism","volume":"67","author":"Gaspard","year":"2003","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2010.02.009_bib29","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.fertnstert.2006.11.137","article-title":"Evaluation of effects of an oral contraceptive containing ethinylestradiol combined with drospirenone on adrenal steroidogenesis in hyperandrogenic women with polycystic ovary syndrome","volume":"88","author":"De Leo","year":"2007","journal-title":"Fertil Steril"},{"key":"10.1016\/j.contraception.2010.02.009_bib30","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.contraception.2004.05.013","article-title":"Efficacy and safety of a low-dose 24-day combined oral contraceptive containing 20 micrograms ethinylestradiol and 3 mg drospirenone","volume":"70","author":"Bachmann","year":"2004","journal-title":"Contraception"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782410000533?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782410000533?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,10]],"date-time":"2018-12-10T18:28:10Z","timestamp":1544466490000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782410000533"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,8]]}},"alternative-id":["S0010782410000533"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2010.02.009","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.5793960.5776061","asserted-by":"object"}]},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2010,8]]}}}